BPA for evrysdi - base year with four one-year options
Ended Awarded Last action
- Contract number
- 36E79721A0011
- Awardee
-
Genentech Usa, Inc. UEI SA85BMHCTXK5
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $1,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This Blanket Purchase Agreement was awarded by the Department of Veterans Affairs National Acquisition Center to Genentech USA, Inc. for the procurement of Evrysdi. The BPA has a potential value of $1 million and a period of performance from March 12, 2021 through September 14, 2023, with four one-year option periods.
The BPA was established against the Pharmaceuticals and Drugs GSA Schedule and provides a contracting vehicle for ordering Evrysdi to treat spinal muscular atrophy. Spinal muscular atrophy is a genetic disease that affects the motor nerve cells in the spinal cord, leading to progressive muscle weakness. Evrysdi is an FDA-approved treatment that targets the underlying genetic root cause of the condition. The BPA aims to facilitate Department of Veterans Affairs medical centers obtaining this treatment for veterans suffering from spinal muscular atrophy.
No set-aside provisions were applied to this single-award BPA. Genentech will supply Evrysdi to Department of Veterans Affairs customers nationwide through September 2023, with options to extend, helping the agency meet the specialized health needs of veterans with rare genetic disorders. The BPA establishes standardized terms, conditions, and prices for this important treatment while maintaining streamlined ordering procedures.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Legal Contract Cancellation | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79721A0011?
36E79721A0011 was awarded to Genentech Usa, Inc. by National Acquisition Center (Headquarters) on March 12, 2021.
How much is contract 36E79721A0011 worth?
36E79721A0011's own ceiling is $1,000,000.
Who can order from contract 36E79721A0011?
36E79721A0011 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79721A0011 under another contract?
Yes. 36E79721A0011 is a blanket purchase agreement under V797D60724, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79721A0011 competed?
The extent of competition for 36E79721A0011 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV